TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -2 | -8 | -6 | 4 | -2 | -39 | -9 |
| S | %wins | 50 | 50 | 75 | 50 | 50 | 100 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/21/15 19:18 | 4/21/15 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | M.d | 157 | 2.61 | 33 | 60 | 31 | 257 | D | 287 | 140 | 53 | 28 | 5 | 14 | 6 | 4 | -3 | -22 | -21 | -19 | -48 | -53 |
4/21/15 19:18 | 4/21/15 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | S.d | -1,595 | 55.00 | 33 | -29 | -10 | 257 | D | 287 | 140 | 53 | 28 | 5 | 14 | 6 | 4 | -3 | -22 | -21 | -19 | -48 | -53 |
1/13/15 16:05 | 1/12/15 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | M.d | 117 | 1.46 | 33 | 80 | 55 | 226 | D | 187 | 77 | 15 | 16 | 1 | 6 | 12 | 6 | 1 | 4 | 14 | 26 | 9 | -28 |
1/13/15 16:05 | 1/12/15 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | S.d | -1,583 | 41.00 | 33 | -39 | -15 | 226 | D | 187 | 77 | 15 | 16 | 1 | 6 | 12 | 6 | 1 | 4 | 14 | 26 | 9 | -28 |
11/5/14 20:06 | 11/3/14 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | S | -1,076 | 44.27 | 33 | -24 | -12 | 183 | D | 248 | 105 | 65 | 24 | 16 | 22 | -4 | -2 | -9 | -16 | -6 | 11 | -3 | -35 |
10/22/14 20:02 | 10/21/14 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | M.d | 312 | 1.48 | 33 | 210 | 207 | D | 216 | 102 | 72 | 20 | 13 | 18 | 19 | 15 | 2 | 4 | -9 | -1 | 34 | -40 | |
10/22/14 20:02 | 10/21/14 | AKRX | Akorn Inc | LA | Health | Drug | Pharmaceutical Preparations | Silverberg Mark M | IL | O | EVP,Ops | S.d | -2,900 | 40.00 | 33 | -72 | -26 | 207 | D | 216 | 102 | 72 | 20 | 13 | 18 | 19 | 15 | 2 | 4 | -9 | -1 | 34 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |